Summary
Danaher Corporation (DHR) filed an 8-K on January 9, 2023, to furnish a press release and presentation slides ahead of their J.P. Morgan Healthcare Conference appearance on January 10, 2023. These documents provide insights into the company's anticipated financial performance for the fourth quarter and full year 2022. While specific financial figures are not detailed within the 8-K text itself, the furnished materials are expected to offer guidance and commentary on key operational and financial metrics, including revenue, earnings, and potentially divisional performance. Investors should review the referenced press release and presentation slides for detailed financial expectations and strategic outlook.
Key Highlights
- 1Danaher Corporation (DHR) issued an 8-K filing on January 9, 2023.
- 2The filing furnished a press release and presentation slides related to the company's financial performance.
- 3These materials were prepared in advance of Danaher's participation in the J.P. Morgan Healthcare Conference on January 10, 2023.
- 4The furnished documents are expected to provide anticipated financial performance data for the fourth quarter of 2022.
- 5Information regarding the full year 2022 financial performance is also expected to be included in the presentation slides.
- 6The content is incorporated by reference and is not deemed 'filed' for certain regulatory purposes, but provides important forward-looking information.
- 7Investors should refer to the press release and presentation slides for specific financial details and commentary.
Frequently Asked Questions
The main purpose of this 8-K filing is to provide investors with advance notice and preliminary information regarding Danaher's anticipated financial performance for the fourth quarter and full year 2022. This information is being shared in conjunction with their participation in the J.P. Morgan Healthcare Conference.
The specific financial performance details are not included directly in the body of the 8-K filing itself. Instead, the filing states that a press release (Exhibit 99.1) and selected presentation slides (Exhibit 99.1 PRE) furnished with the report contain this information. Investors should consult these referenced exhibits for the detailed data.
This filing does not contain the finalized official financial results for Q4 2022. Instead, it provides 'anticipated' or expected financial performance as commentary ahead of a conference presentation. The official results will likely be reported in a subsequent 10-Q filing.
The statement that the information 'shall not be deemed 'filed'' for purposes of Section 18 of the Exchange Act means that liability under that specific section (which deals with liability for misleading statements in documents filed with the SEC) does not automatically attach to this furnished information. However, the anti-fraud provisions of federal securities laws still apply, and the information is still considered material and relevant for investors to review.